Lupus News Today Home | Lupus News Today
WEBParvovirus, mpox, and COVID-19: 3 reasons to heighten precautions. Summer news reports show that COVID-19 is surging again. The World Health Organization has declared the mpox outbreak a global health emergency. And human parvovirus B19, which can cause fifth disease, is spreading across the U.S. Scientists are finding that, in …
Fashioning my own Top 10 ‘spoon commandments’ for health
WEB12 hours ago · No. 3: Gain strength. Develop a gentle movement routine to build strength, flexibility, and mind-body connection. Start with light stretching and squats, maybe 10 to 15 repetitions a day, if you can; then gradually increase that number. Swim, practice low-impact yoga, or walk barefoot on grass or dirt.
Lupuzor Shows Strong Safety Results as Lupus Treatment in Phase …
WEBby Alice Melão September 29, 2017. New data from an ongoing Phase 3 clinical trial continues to demonstrate that ImmuPharma ‘s Lupuzor is safe for the treatment of systemic lupus erythematosus (SLE) patients. To date, all trial participants have reached the six-month stage, and one out of four have completed the full 12-month study.
Lupus overview - Lupus News Today
WEBFeb 9, 2023 · Lupus is a chronic disorder wherein the immune system attacks the body’s own healthy tissue. Lupus can affect virtually every part of the body, including the skin, kidneys, joints, brain, heart, and lungs, resulting in a range of symptoms. Systemic lupus erythematosus (SLE) — often referred to simply as lupus — is the most common and ...
Phase 3 trials of ianalumab for SLE, lupus nephritis now enrolling
WEBJun 15, 2023 · All three trials are being sponsored by Novartis, the company developing ianalumab. Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, recently announced that it will be teaming up with Novartis to help run these trials at sites in North America. “We believe this collaboration between Lupus Therapeutics and Novartis Pharmaceuticals will provide a significant ...
Lupkynis protects kidneys in lupus nephritis for up to 3 years
WEBJul 24, 2023 · The therapy is an oral medication approved in US, UK, and EU. by Margarida Maia July 24, 2023. Lupkynis (voclosporin) continues to be safe and to protect kidney function when taken for up to three years by patients with lupus nephritis, a kidney complication of lupus. That’s according to the full results from AURORA 2 …
Long-term safety of Lupkynis for SLE confirmed in AURORA trial
WEBApr 10, 2023 · New top-line data show participants in the Lupkynis treatment arm of the now completed Phase 3 AURORA trial (NCT03021499) had similar kidney biopsy (histologic) findings as those in the active control arm receiving mycophenolate mofetil, an immunosuppressant sold under the brand name CellCept, and low-dose steroids alone.. These results contrast with the well-known kidney-related side effects ...
News Archives - Lupus News Today
WEBJoint pain very common in lupus, affects patients’ life quality: Study. The vast majority of people with systemic lupus erythematosus (SLE) experience musculoskeletal symptoms, marked by pain, ache, discomfort, and numbness, often in the joints, primarily the hands, wrists, and knees. That’s according to a study from researchers in Egypt ...
FDA Clears Automated Diagnosis Tests for Lupus and ANCA …
WEBJun 1, 2018 · The U.S. Food and Drug Administration (FDA) has approved new automated diagnostic tests for lupus and ANCA-associated vasculitis, a form of blood vessel inflammation, Grifols, which will market these tests, announced. The two use the HELIOS system, developed by AESKU, which is the first and only automated system capable of processing and ...
2 New Meds Found to Change Lupus Nephritis Treatment: Report
WEBJan 23, 2023 · Still many patients on high-dose corticosteroids, report finds. The analysis included data from 962 people with the disease in the U.S., as well as insights from 138 rheumatologists — autoimmune disease specialists — and 104 nephrologists, or …